Rosen J and Miner JN: The search for safer glucocorticoid receptor ligands. Endocr Rev 26:452-464, 2005.
Kofler R: The molecular basis of glucocorticoid-induced apoptosis of lymphoblastic leukemia cells. Histochem Cell Biol 114:1-7, 2000.
Evans-Storms RB and Cidlowski JA: Delineation of an antiapoptotic action of glucocorticoids in hepatoma cells: the role of nuclear factor-kappaB. Endocrinology 141:1854-1862, 2000.
Bernard-Marty C, Cardoso F and Piccart MJ: Use and abuse of taxanes in the management of metastatic breast cancer. Eur J Cancer 39:1978-1989, 2003.
Zhang C, Beckermann B, Kallifatidis G, Liu Z, Rittgen W, Edler L, Büchler P, Debatin KM, Büchler MW, Friess H and Herr I: Corticosteroids induce chemotherapy resistance in the majority of tumour cells from bone, brain, breast, cervix, melanoma and neuroblastoma. Int J Oncol 29:1295-1301, 2006.
Moutsatsou P and Papavassiliou AG: The glucocorticoid receptor signalling in breast cancer. J Cell Mol Med 12:145-163, 2008.
Beato M, Herrlich P and Schütz G: Steroid hormone receptors: many actors in search of a plot. Cell 83:851-857, 1995.
Arbyn M, Autier P and Ferlay J: Burden of cervical cancer in the 27 member states of the European Union: estimates for 2004. Ann Oncol 18:1423-1425, 2007
Sørensen GV, Cronin-Fenton DP, Sørensen HT, Ulrichsen SP, Pedersen L and Lash TL: Use of glucocorticïds and risk of breast cancer: a Danish population-based case-control study. Breast Cancer Res 14:R21, 2012.
Gong H, Jarzynka MJ, Cole TJ, Lee JH, Wada T, Zhang B, Gao J, Song WC, DeFranco DB, Cheng SY and Xie W: Glucocorticoids antagonize estrogens by glucocorticoid receptor-mediated activation of estrogen sulfotransferase. Cancer Res 68:7386-7393, 2008.
Skor MN, Wonder EL, Kocherginsky M, Goyal A, Hall BA, Cai Y and Conzen SD: Glucocorticoid receptor antagonism as a novel therapy for triple-negative breast cancer. Clin Cancer Res 19:6163-6172, 2013.
Lien HC, Lu YS, Cheng AL, Chang WC, Jeng YM, Kuo YH, Huang CS, Chang KJ and Yao YT: Differential expression of glucocorticoid receptor in human breast tissues and related neoplasms. J Pathol 209:317-327, 2006.
Buxant F, Engohan-Aloghe C and Noël JC: Estrogen receptor, progesterone receptor, and glucocorticoid receptor expression in normal breast tissue, breast in situ carcinoma, and invasive breast cancer. Appl Immunohistochem Mol Morphol 18:254-257, 2010.
Vilasco M, Communal L, Hugon-Rodin J, Penault-Llorca F, Mourra N, Wu Z, Forgez P and Gompel A; BRACAPS: Loss of glucocorticoid receptor activation is a hallmark of BRCA1-mutated breast tissue. Breast Cancer Res Treat 142:283-296, 2013.
Conde I, Paniagua R, Fraile B, Lucio J and Arenas MI: Glucocorticoid receptor changes its cellular location with breast cancer development. Histol Histopathol 23:77-85, 2008.
Krishnan AV, Swami S and Feldman D: Estradiol inhibits glucocorticoid receptor expression and induces glucocorticoid resistance in MCF-7 human breast cancer cells. J Steroid Biochem Mol Biol 77:29-37, 2001.
Govindan MV, Devic M, Green S, Gronemeyer H and Chambon P: Cloning of the human glucocorticoid receptor cDNA. Nucleic Acids Res 13:8293-8304, 1985.
Oakley RH and Cidlowski JA: Cellular processing of the glucocorticoid receptor gene and protein: new mechanisms for generating tissue-specific actions of glucocorticoids. J Biol Chem 286:3177-3184, 2011.
Moutsatsou P and Papavassiliou AG: The glucocorticoid receptor signalling in breast cancer. J Cell Mol Med 12:145-163, 2008.
Lippman M, Bolan G and Huff K: The effects of glucocorticoids and progesterone on hormone-responsive human breast cancer in long-term tissue culture. Cancer Res 36:4602-4609, 1976.
Huff KK, Knabbe C, Lindsey R, Kaufman D, Bronzert D, Lippman ME and Dickson RB: Multihormonal regulation of insulin-like growth factor-I-related protein in MCF-7 human breast cancer cells. Mol Endocrinol 2:200-208, 1988.
Schorr K and Furth PA: Induction of bcl-xL expression in mammary epithelial cells is glucocorticoid-dependent but not signal transducer and activator of transcription 5-dependent. Cancer Res 60:5950-5953, 2000.
Wu W, Pew T, Zou M, Pang D and Conzen SD: Glucocorticoid receptor-induced MAPK phosphatase-1 (MPK-1) expression inhibits paclitaxel-associated MAPK activation and contributes to breast cancer cell survival. J Biol Chem 280:4117-4124, 2005.
Wu W, Chaudhuri S, Brickley DR, Pang D, Karrison T and Conzen SD: Microarray analysis reveals glucocorticoid-regulated survival genes that are associated with inhibition of apoptosis in breast epithelial cells. Cancer Res 64:1757-1764, 2004.
Wang H, Li M, Rinehart JJ and Zhang R: Dexamethasone as a chemoprotectant in cancer chemotherapy: hematoprotective effects and altered pharmacokinetics and tissue distribution of carboplatin and gemcitabine. Cancer Chemother Pharmacol 53:459-467, 2004.
